← Leaderboards
David Baker
University Of Washington
$22,630,205
Attributed
$25,172,046
Total exposure
54
Grants
45
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,172,046 · 54
By mechanism
R01$12,998,776 · 6
U19$6,094,589 · 3
RL1$1,856,778 · 1
P41$1,316,093 · 33
P50$937,287 · 1
U01$717,924 · 1
Top collaborators
- Deborah L. Fuller5 shared
- David Veesler5 shared
- Paul Yager2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Andrew N Hoofnagle$12,195,295
- Frank P Dimaio$2,961,120
- Paul Yager$14,080,210
- Richard A Bonneau$5,870,085
- Anne Kathryn Churchland$9,994,228
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructureDesignBaseUnited States National Institutes Of HealthAffinitySpecificityIn VivoGrantResourcesProtein EngineeringSourceBindingSurfaceIn VitroPeptidesProtein StructureAntibodiesComplexComputing MethodologiesStructural BiologyResolutionFundingEngineering
Grant awards (108)
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$671,529
R01 · FY2025 · AI · contact PI
MATCHMAKERS$365,699
OT2 · FY2025 · CA · contact PI
Project 1: Computational methods$3,753,275
U19 · FY2024 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$692,102
R01 · FY2024 · AI · contact PI
Project 4: Novel reagent development to enable molecular characterization$442,918
U19 · FY2024 · AG · contact PI
MATCHMAKERS$327,039
OT2 · FY2024 · CA · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$703,773
R01 · FY2023 · AI · contact PI
Designed Vehicles for Blood Brain Barrier Traversal$495,530
R01 · FY2023 · AG · contact PI
Project 4: Novel reagent development to enable molecular characterization$455,358
U19 · FY2023 · AG · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$338,953
R01 · FY2023 · CA · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$713,861
R01 · FY2022 · AI · contact PI
Designed Vehicles for Blood Brain Barrier Traversal$504,455
R01 · FY2022 · AG · contact PI
Project 4: Novel reagent development to enable molecular characterization$448,778
U19 · FY2022 · AG · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$367,987
R01 · FY2022 · CA · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$338,955
R01 · FY2022 · CA · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$723,634
R01 · FY2021 · AI · contact PI
Designed Vehicles for Blood Brain Barrier Traversal$517,844
R01 · FY2021 · AG · contact PI
Project 4: Novel reagent development to enable molecular characterization$455,358
U19 · FY2021 · AG · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$345,873
R01 · FY2021 · CA · contact PI
Project 4: Novel reagent development to enable molecular characterization$538,902
U19 · FY2020 · AG · contact PI
Designed Vehicles for Blood Brain Barrier Traversal$485,848
R01 · FY2020 · AG · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$341,617
R01 · FY2020 · CA · contact PI
Designed Vehicles for Blood Brain Barrier Traversal$535,766
R01 · FY2019 · AG · contact PI
Design of de novo interleukin mimics for targeted immunotherapy$355,489
R01 · FY2019 · CA · contact PI
Rationally-designed modulators of the a-beta aggregation cascade$189,056
P50 · FY2019 · AG · contact PI
Rationally-designed modulators of the a-beta aggregation cascade$198,910
P50 · FY2018 · AG · contact PI
High resolution structure modeling with Rosetta$278,969
R01 · FY2017 · GM · contact PI
A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes$188,696
R21 · FY2017 · AI · contact PI
Rationally-designed modulators of the a-beta aggregation cascade$183,105
P50 · FY2017 · AG · contact PI
High resolution structure modeling with Rosetta$278,969
R01 · FY2016 · GM · contact PI
A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes$221,788
R21 · FY2016 · AI · contact PI
Rationally-designed modulators of the a-beta aggregation cascade$183,108
P50 · FY2016 · AG · contact PI
High resolution structure modeling with Rosetta$278,969
R01 · FY2015 · GM · contact PI
Rationally-designed modulators of the a-beta aggregation cascade$183,108
P50 · FY2015 · AG · contact PI
High resolution structure modeling with Rosetta$278,969
R01 · FY2014 · GM · contact PI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)$144,274
U01 · FY2014 · GM · contact PI
High resolution structure modeling with Rosetta$262,869
R01 · FY2013 · GM · contact PI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)$139,224
U01 · FY2013 · GM · contact PI
High resolution structure modeling with Rosetta$292,077
R01 · FY2012 · GM · contact PI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)$144,274
U01 · FY2012 · GM · contact PI
Computational Design of an LAGLIDADGs with Novel Recognition Specificities (Compo$364,051
RL1 · FY2011 · GM · contact PI
High resolution structure modeling with Rosetta$292,077
R01 · FY2011 · GM · contact PI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)$144,065
U01 · FY2011 · GM · contact PI
DETERMINATION OF THE STRUCTURES OF SYMMETRIC PROTEIN OLIGOMERS FROM NMR CHEMICAL$64,880
P41 · FY2011 · RR · contact PI
A DE NOVO PROTEIN BINDING PAIR BY COMPUTATIONAL DESIGN AND DIRECTED EVOLUTION$64,880
P41 · FY2011 · RR · contact PI
COMPUTATIONAL DESIGN OF PROTEINS TARGETING THE STEM REGION OF INFLUENZA$64,880
P41 · FY2011 · RR · contact PI
ROSETTA BASED MODELING OF CRYO-EM MAP$49,049
P41 · FY2011 · RR · contact PI
Computational Design of an LAGLIDADGs with Novel Recognition Specificities (Compo$378,760
RL1 · FY2010 · GM · contact PI
High resolution structure modeling with Rosetta$295,027
R01 · FY2010 · GM · contact PI
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)$146,087
U01 · FY2010 · GM · contact PI
DE NOVO DESIGN OF PROTEIN-PROTEIN INTERACTIONS$38,889
P41 · FY2010 · RR · contact PI
STRUCTURE PREDICTION WITH LIMITED EXPERIMENTAL CONSTRAINTS$38,889
P41 · FY2010 · RR · contact PI
PREDICTION OF MEMBRANE PROTEIN STRUCTURES WITH COMPLEX TOPOLOGIES USING LIMITED$38,889
P41 · FY2010 · RR · contact PI
AB INITIO MODELING BASED ON CRYOEM MAP$21,500
P41 · FY2010 · RR · contact PI
Computational Design of an LAGLIDADGs with Novel Recognition Specificities (Compo$382,587
RL1 · FY2009 · GM · contact PI
Protein-Protein Interactions$75,306
R01 · FY2009 · GM · contact PI
MODELING THE STRUCTURE OF A RECEPTOR WITH TWO ASSOCIATING TRANSMEMBRANE DOMAINS$31,337
P41 · FY2009 · RR · contact PI
PREDICTION OF MEMBRANE PROTEIN STRUCTURES WITH COMPLEX TOPOLOGIES USING LIMITED$31,337
P41 · FY2009 · RR · contact PI
DE NOVO DESIGN OF PROTEIN-PROTEIN INTERACTIONS$31,337
P41 · FY2009 · RR · contact PI
AB INITIO MODELING BASED ON CRYOEM MAP$17,381
P41 · FY2009 · RR · contact PI
CLINICAL TRIAL: A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MP$240
M01 · FY2009 · RR · contact PI
Computational Design of an LAGLIDADGs with Novel Recognition Specificities (Compo$328,314
RL1 · FY2008 · GM · contact PI
Protein-Protein Interactions$242,404
R01 · FY2008 · GM · contact PI
PREDICTING RMSD OF PREDICTED PROTEIN STRUCTURES$80,340
P41 · FY2008 · RR · contact PI
DE NOVO PROTEIN INTERFACE DESIGN$70,880
P41 · FY2008 · RR · contact PI
CLINICAL TRIAL: A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MP$2,507
M01 · FY2008 · RR · contact PI
Computational Design of an LAGLIDADGs with Novel Recognition Specificities (Compo$403,066
RL1 · FY2007 · GM · contact PI
Protein-Protein Interactions$242,587
R01 · FY2007 · GM · contact PI
PREDICTING MOLECULAR FUNCTION FOR PROTEINS USING GO AND STRUCTURE INFORMATION$63,471
P41 · FY2007 · RR · contact PI
PREDICTING RMSD OF PREDICTED PROTEIN STRUCTURES$55,285
P41 · FY2007 · RR · contact PI
DE NOVO PROTEIN INTERFACE DESIGN$55,283
P41 · FY2007 · RR · contact PI
TEV PROTEASE ENHANCEMENT$36,950
P41 · FY2007 · RR · contact PI
Low-resolution structural genomics of nucleases$31,575
R03 · FY2007 · TW · contact PI
AB INITIO MODELING BASED ON CRYOEM MAP$16,289
P41 · FY2007 · RR · contact PI
A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MPL VACCINE$4,279
M01 · FY2007 · RR · contact PI
THE VAGINAL/ORAL CONNECTION$2,615
M01 · FY2007 · RR · contact PI
Protein-Protein Interactions$250,015
R01 · FY2006 · GM · contact PI
PREDICTING MOLECULAR FUNCTION FOR PROTEINS USING GO AND STRUCTURE INFORMATION$60,095
P41 · FY2006 · RR · contact PI
PREDICTING RMSD OF PREDICTED PROTEIN STRUCTURES$48,406
P41 · FY2006 · RR · contact PI
Low-resolution structural genomics of nucleases$32,518
R03 · FY2006 · TW · contact PI
A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MPL VACCINE$32,359
M01 · FY2006 · RR · contact PI
TOWARD HIGH-RESOLUTION DE NOVO STRUCTURE PREDICTION FOR SMALL PROTEINS$21,471
P41 · FY2006 · RR · contact PI
SECONDARY STRUCTURE MOTIF MATCHING IN ROSETTA$21,471
P41 · FY2006 · RR · contact PI
PROTEIN STRUCTURE PREDICTION OF YEAST GENOME$21,471
P41 · FY2006 · RR · contact PI
AB INITIO MODELING BASED ON CRYOEM MAP$15,059
P41 · FY2006 · RR · contact PI
SEMINARS ON PROGRESS IN HIGH RESOLUTION MODELING OF MACROMOLECULAR STRUCTURES A$4,181
P41 · FY2006 · RR · contact PI
Protein-Protein Interactions$256,213
R01 · FY2005 · GM
PREDICTING MOLECULAR FUNCTION FOR PROTEINS USING GO AND STRUCTURE INFORMATION$55,040
P41 · FY2005 · RR
Low-resolution structural genomics of nucleases$39,800
R03 · FY2005 · TW
LARGE SCALE STRUCTURE PREDICTION FACILITY$18,755
P41 · FY2005 · RR
DEVELOPMENT OF THE AB INITIO STRUCTURE PREDICTION ALGORITHMS$16,587
P41 · FY2005 · RR
PROTEIN STRUCTURE PREDICTION OF YEAST GENOME$16,587
P41 · FY2005 · RR
GENE ONTOLOGY TERM PREDICTION USING ROSETTA/GINZU DATA$16,587
P41 · FY2005 · RR
SEMINARS AND REVIEWS ON PROTEIN STRUCTURE PREDICTION$8,294
P41 · FY2005 · RR
A STUDY TO ASSESS THE PROPHYLACTIC EFFICACY/SAFETY OF GD-ALUM/MPL VACCINE$1,484
M01 · FY2005 · RR
PROTEIN STRUCTURE PREDICTION WEB-BASED ANALYSIS TOOL$30,818
P41 · FY2004 · RR
STRUCTURAL DOMAIN IDENTIFICATION FROM SEQUENCE$21,004
P41 · FY2004 · RR
PROTEIN STRUCTURE PREDICTION OF YEAST GENOME$21,004
P41 · FY2004 · RR
GENE ONTOLOGY TERM PREDICTION$21,004
P41 · FY2004 · RR
LARGE SCALE STRUCTURE PREDICTION FACILITY$21,004
P41 · FY2004 · RR
SEMINARS ON PROTEIN STRUCTURE PREDICTION$5,509
P41 · FY2004 · RR
FOLDING AND DESIGN OF ALPHA BETA SANDWICH PROTEINS$200,643
R01 · FY2003 · GM
MECHANISM OF FOLDING OF THE SH3 DOMAIN$258,587
R01 · FY2002 · GM
FOLDING AND DESIGN OF ALPHA BETA SANDWICH PROTEINS$199,857
R01 · FY2002 · GM
MECHANISM OF FOLDING OF THE SH3 DOMAIN$251,204
R01 · FY2001 · GM
FOLDING AND DESIGN OF ALPHA BETA SANDWICH PROTEINS$189,241
R01 · FY2001 · GM
MECHANISM OF FOLDING OF THE SH3 DOMAIN$246,216
R01 · FY2000 · GM
FOLDING AND DESIGN OF ALPHA BETA SANDWICH PROTEINS$195,361
R01 · FY2000 · GM